Skip to main content
OpenTrials
Completed

NCT Number: NCT00364624

Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Medicine, Princess Margaret Hospital

Kowloon, Hong Kong SAR, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Histologically proven primary lung cancer
  • Newly diagnosed
  • No specific treatment given
  • No active infection in the previous week
  • No general anesthesia in the previous week

Exclusion criteria

  • Known adrenal disease
  • Receiving exogenous systemic corticosteroids
  • Concomitant illness known to affect adrenal function. e.g. active TB

Sponsors and collaborators

Lead sponsor

Princess Margaret Hospital, Hong Kong

Other Gov

Registry information

Official study title

Adrenal Cortical Function in Patients With Newly Diagnosed Lung Cancer

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
Aug 15, 2006
Registry last updated
Jan 16, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.